clostridium botulinum toxin
Biologicalexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
3
Phase 4
0
Earliest trial started Mar 30, 2016 (NCT03216408)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- AcetylcholinesteraseINHIBITOR
ACHE inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04113941 | Phase 3 | Aug 23, 2019 | Medy-Tox |
| NCT03216473 | Phase 3 | May 25, 2016 | Medy-Tox |
| NCT03216408 | Phase 3 | Mar 30, 2016 | Medy-Tox |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medy-Tox | For profit | 3 | 3 | 1 | 2016 |
1 organizations
Page 1 / 1